Regadenoson: all 49 studies that test it
Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.
- Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PETRecruitingNCT05583721Phase 2
- A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric PatientsRecruitingNCT04604782Phase 1/2
- New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF)RecruitingNCT04600115Early Phase 1
- Allograft Dysfunction in Heart TransplantRecruitingNCT03102125Phase 4
- Treat COVID-19 Patients With RegadenosonCompletedNCT04606069Phase 1/2Results posted
- The MATCH Investigation: CT Myocardial Perfusion and CT-FFR vs PET MPICompletedNCT04316676Not applicableResults posted
- Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow ReserveTerminatedNCT03249272Phase 4Results posted
- Use of Lexiscan for Myocardial Stress Perfusion Computed Tomography With a 3rd Generation Dual Source CT SystemCompletedNCT03103061Phase 2Results posted
- Stress Cardiac MRI for Evaluation of Nonspecific Allograft DysfunctionCompletedNCT02597543Phase 4Results posted
- Myocardial Perfusion, Oxidative Metabolism, and Fibrosis in HFpEFCompletedNCT02589977Phase 4Results posted
- Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson AdministrationCompletedNCT02389738Early Phase 1Results posted
- Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle TrackingCompletedNCT02130453Phase 4Results posted
- Characterization of Changes in Ventricular Mechanics in Response to Lexiscan Stress Using Tagged Cine Cardiac Magnetic Resonance ImagingCompletedNCT02115308Phase 4Results posted
- Stress CT Perfusion in Patients With Chest PainCompletedNCT01969916Not applicableResults posted
- Characterization of Myocardial Blood Flow Measurements Using Lexiscan®™ (Regadenoson) (Lexiscan®™) Rubidium-82 Myocardial Perfusion PET: A Temporal-Dependency InvestigationCompletedNCT01919450Phase 4Results posted
- Heart Rate Response to Regadenoson and Sudden Cardiac DeathCompletedNCT01842035Not applicableResults posted
- A Phase II Trial of Regadenoson in Sickle Cell AnemiaCompletedNCT01788631Phase 2Results posted
- Development of a PET-MR Myocardial Perfusion Examination Using RegadenosonCompletedNCT01779869Phase 4Results posted
- Absolute Quantification of Coronary Flow Reserve by Stress Perfusion MRICompletedNCT01655043Phase 2Results posted
- A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)CompletedNCT01618669Phase 3Results posted
- Microvascular Blood Flow in Sickle Cell AnemiaCompletedNCT01566890Not applicableResults posted
- Regadenoson Real Time Perfusion Imaging Trial-OptisonCompletedNCT01489176Phase 3Results posted
- Myocardial Blood Flow by PET and N-13 Ammonia During Regadenoson vs Adenosine StressCompletedNCT01370265Not applicableResults posted
- A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)CompletedNCT01334918Phase 2Results posted
- Comparison of Intravenous Adenosine Infusion With Regadenoson Bolus for Inducing Maximal Coronary HyperemiaCompletedNCT01161121Phase 1Results posted
- Integrated Dual Exercise and Lexiscan Positron Emission Tomography: IDEALPETCompletedNCT01109992Phase 4Results posted
- Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell DiseaseCompletedNCT01085201Phase 1Results posted
- Maximal Bruce Protocol With the Use of Regadenoson For Myocardial Perfusion Stress TestingCompletedNCT01026012Not applicableResults posted
- Regadenoson Combined With Symptom-Limited Exercise in Patients Undergoing Myocardial Perfusion ImagingCompletedNCT01021618Not applicableResults posted
- Regadenoson Blood Flow in Type 1 Diabetes (RABIT1D)CompletedNCT01019486Phase 4Results posted
- Stress Testing and Cardiac Magnetic ResonanceCompletedNCT00871260Phase 4Results posted
- A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal ImpairmentCompletedNCT00863707Phase 4Results posted
- A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary DiseaseCompletedNCT00862641Phase 4Results posted
- Effects of Body Mass Index on the Hyperemic Response to RegadenosonCompletedNCT00859833Not applicableResults posted
- Multivariable Assessment of Coronary Artery Disease Using Cardiac CT ImagingCompletedNCT00857792Not applicableResults posted
- Regadenoson R-T Perfusion Imaging TrialCompletedNCT00837369Phase 1Results posted
- Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR)TerminatedNCT00763035Early Phase 1Results posted
- Regadenoson Infusion of Marginalized Donor Lungs in an EVLP SystemCompletedNCT04521569Early Phase 1
- Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade GliomasTerminatedNCT03971734Phase 1
- Study to Evaluate Adenosine 2A Receptor Agonist (Regadenoson) in Patients Undergoing Lung TransplantationStatus unknownNCT03072589Phase 1
- Comparison of Quantitative MRI Perfusion Methods With Quantitative PET Perfusion ImagingWithdrawnNCT02608944Not applicable
- Regadenoson for Acute Vasoreactivity Testing in Pulmonary HypertensionTerminatedNCT02220634Not applicable
- Repeat Dose Tolerance Study of Regadenoson in Healthy SubjectsCompletedNCT01918995Phase 1
- Phase Analysis and Obstructive CAD on Rubidium PETWithdrawnNCT01840696Phase 2
- Diagnostic Study of Rapid Regadenoson Stress Cardiovascular Magnetic Resonance (CMR) to Detect Coronary Artery DiseaseStatus unknownNCT01446094Phase 4
- Stress Echocardiography Study With RegadenosonTerminatedNCT00907764Phase 2
- Myocardial Perfusion Magnetic Resonance Imaging Using RegadenosonCompletedNCT00881218Early Phase 1
- ADVANCE MPI 2: Study of Regadenoson Versus Adenoscan® in Patients Undergoing Myocardial Perfusion Imaging (MPI)CompletedNCT00208312Phase 3
- ADVANCE MPI 1: Study of Regadenoson Versus Adenoscan® in Patients Undergoing Myocardial Perfusion Imaging (MPI)CompletedNCT00208299Phase 3